Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties.
暂无分享,去创建一个
[1] C. Pichot,et al. Covalent immobilization of biological molecules to maleic anhydride and methyl vinyl ether copolymers : A physico-chemical approach , 1999 .
[2] J. Feijen,et al. Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers , 2000, Journal of drug targeting.
[3] P Couvreur,et al. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.
[4] D. Bazile,et al. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.
[5] I. Colombo,et al. Investigation of surface properties of some polymers by a thermodynamic and mechanical approach: possibility of predicting mucoadhesion and biocompatibility. , 1994, Biomaterials.
[6] A. Vila,et al. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[7] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[8] V. Torchilin. Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.
[9] M. A. Arangoa,et al. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. , 2002, International journal of pharmaceutics.
[10] J. Irache,et al. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.
[11] J. Robinson,et al. Bioadhesive-based dosage forms: the next generation. , 2000, Journal of pharmaceutical sciences.
[12] W. Saltzman,et al. Synthetic polymers alter the structure of cervical mucus. , 2001, Biomaterials.
[13] S. Yamashita,et al. Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract , 1997 .
[14] G. Halbert,et al. The in Vitro Cell Association of Invasin Coated Polylactide-Co-glycolide Nanoparticles , 2000, Pharmaceutical Research.
[15] P. Dubin,et al. Hydrophobic hypercoiling in copolymers of maleic acid and alkyl vinyl ethers , 1967 .
[16] N Hussain,et al. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. , 2001, Advanced drug delivery reviews.
[17] M. Wirth,et al. Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[18] Gilles Ponchel,et al. Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics , 2001, Pharmaceutical Research.
[19] T. Kissel,et al. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] G. Russell-Jones,et al. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. , 1999, International journal of pharmaceutics.
[21] Alexander T. Florence,et al. Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat , 1997, Pharmaceutical Research.
[22] Lisbeth Illum,et al. Long circulating microparticulate drug carriers , 1995 .
[23] Soriano,et al. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. , 2000, Colloids and surfaces. B, Biointerfaces.
[24] Ji Qian,et al. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. , 2004, World journal of gastroenterology.
[25] J. Demeester,et al. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus , 2002, Gene Therapy.
[26] O. Bourdon,et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. , 2001, Biomaterials.
[27] Y. Huang,et al. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[28] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[29] E. Schacht,et al. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. , 1998, Journal of pharmaceutical sciences.
[30] C. Pichot,et al. Covalent immobilization of bovine serum albumin onto (maleic anhydride-alt-methyl vinyl ether) copolymers , 1999 .
[31] M. Alonso,et al. Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration , 1998, Pharmaceutical Research.